Cargando…

Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis

BACKGROUND: Clinical trials where cancer patients were treated with protease inhibitors have suggested that the serine protease, prostasin, may act as a tumour suppressor. Prostasin is proteolytically activated by the serine protease, matriptase, which has a very high oncogenic potential. Prostasin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Selzer-Plon, Joanna, Bornholdt, Jette, Friis, Stine, Bisgaard, Hanne C, Lothe, Inger MB, Tveit, Kjell M, Kure, Elin H, Vogel, Ulla, Vogel, Lotte K
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717118/ https://www.ncbi.nlm.nih.gov/pubmed/19555470 http://dx.doi.org/10.1186/1471-2407-9-201

Ejemplares similares

The level of claudin-7 is reduced as an early event in colorectal carcinogenesis
por: Bornholdt, Jette, et al.
Publicado: (2011)

Collagen mRNA levels changes during colorectal cancer carcinogenesis
por: Skovbjerg, Hanne, et al.
Publicado: (2009)

Intestinal PTGS2 mRNA Levels, PTGS2 Gene Polymorphisms, and Colorectal Carcinogenesis
por: Vogel, Lotte K., et al.
Publicado: (2014)

Low ABCB1 Gene Expression Is an Early Event in Colorectal Carcinogenesis
por: Andersen, Vibeke, et al.
Publicado: (2013)

Correction: Low ABCB1 Gene Expression Is an Early Event in Colorectal Carcinogenesis
por: Andersen, Vibeke, et al.
Publicado: (2013)

Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma
por: Lorentzen, Anders, et al.
Publicado: (2007)

Reduced Prostasin (CAP1/PRSS8) Activity Eliminates HAI-1 and HAI-2 Deficiency–Associated Developmental Defects by Preventing Matriptase Activation
por: Szabo, Roman, et al.
Publicado: (2012)

Detection of Active Matriptase Using a Biotinylated Chloromethyl Ketone Peptide
por: Godiksen, Sine, et al.
Publicado: (2013)

The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals
por: Vogel, Lotte K, et al.
Publicado: (2006)

Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study
por: Skjelbred, Camilla Furu, et al.
Publicado: (2006)

Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas
por: Skjelbred, Camilla F, et al.
Publicado: (2007)

High ABCC2 and Low ABCG2 Gene Expression Are Early Events in the Colorectal Adenoma-Carcinoma Sequence
por: Andersen, Vibeke, et al.
Publicado: (2015)

Prostasin: An Epithelial Sodium Channel Regulator
por: Aggarwal, Shakti, et al.
Publicado: (2013)

Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study
por: Guren, Tormod Kyrre, et al.
Publicado: (2017)

Increased mRNA expression levels of ERCC1, OGG1 and RAI in colorectal adenomas and carcinomas
por: Sæbø, Mona, et al.
Publicado: (2006)

Effects of polymorphisms in ERCC1, ASE-1 and RAI on the risk of colorectal carcinomas and adenomas: a case control study
por: Skjelbred, Camilla F, et al.
Publicado: (2006)

Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer
por: Lorentzen, Anders, et al.
Publicado: (2011)

Cytokine expression in mice exposed to diesel exhaust particles by inhalation. Role of tumor necrosis factor
por: Saber, Anne T, et al.
Publicado: (2006)

Regulation of Adrenal Aldosterone Production by Serine Protease Prostasin
por: Ko, Takehiro, et al.
Publicado: (2010)

Association between preeclampsia and prostasin polymorphism in Pakistani females
por: Ejaz, Saima, et al.
Publicado: (2020)

The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study
por: Andersen, Vibeke, et al.
Publicado: (2009)

Molecular constituents of the extracellular matrix in rat liver mounting a hepatic progenitor cell response for tissue repair
por: Vestentoft, Peter Siig, et al.
Publicado: (2013)

Differential Expression of miRNAs in Colorectal Cancer: Comparison of Paired Tumor Tissue and Adjacent Normal Mucosa Using High-Throughput Sequencing
por: Hamfjord, Julian, et al.
Publicado: (2012)

Genetic polymorphism of the prostasin gene in hypertensive pregnant Pakistani females
por: Ejaz, Saima, et al.
Publicado: (2021)

Association between cigarette smoking, APC mutations and the risk of developing sporadic colorectal adenomas and carcinomas
por: Sæbø, Mona, et al.
Publicado: (2006)

Conserved function of the matriptase-prostasin proteolytic cascade during epithelial morphogenesis
por: Drees, Leonard, et al.
Publicado: (2019)

Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study
por: Hamfjord, Julian, et al.
Publicado: (2022)

Prostasin, A Potential Tumor Marker in Ovarian Cancer- A Pilot Study
por: Costa, Fernanda Pires, et al.
Publicado: (2009)

Ibuprofen regulates the expression and function of membrane-associated serine proteases prostasin and matriptase
por: Chai, Andreas C., et al.
Publicado: (2015)

Prostasin regulates PD-L1 expression in human lung cancer cells
por: Chen, Li-Mei, et al.
Publicado: (2021)

Plasma prostasin: a novel risk marker for incidence of diabetes and cancer mortality
por: Bao, Xue, et al.
Publicado: (2022)

Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer
por: Thomsen, Maria, et al.
Publicado: (2016)

Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome
por: Thomsen, Maria, et al.
Publicado: (2018)

The serine protease prostasin regulates hepatic insulin sensitivity by modulating TLR4 signalling
por: Uchimura, Kohei, et al.
Publicado: (2014)

PSP94, an upstream signaling mediator of prostasin found highly elevated in ovarian cancer
por: Ma, J-x, et al.
Publicado: (2014)

Exosome-Mediated Activation of the Prostasin-Matriptase Serine Protease Cascade in B Lymphoma Cells
por: Chen, Li-Mei, et al.
Publicado: (2023)

Non-hematopoietic PAR-2 is essential for matriptase-driven pre-malignant progression and potentiation of ras-mediated squamous cell carcinogenesis
por: Sales, Katiuchia Uzzun, et al.
Publicado: (2014)

Let-7 miRNA-binding site polymorphism in the KRAS 3(′)UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/− cetuximab
por: Kjersem, Janne B, et al.
Publicado: (2012)

Generation and Characterisation of Novel Pancreatic Adenocarcinoma Xenograft Models and Corresponding Primary Cell Lines
por: Wennerström, Anna B., et al.
Publicado: (2014)

FCGR2A and FCGR3A polymorphisms and clinical outcome in metastatic colorectal cancer patients treated with first-line 5-fluorouracil/folinic acid and oxaliplatin +/- cetuximab
por: Kjersem, Janne B, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b6rg6ve024jnphd4buajr4cnbb